TY - JOUR
T1 - Telemedicine quality and outcomes in stroke
T2 - A scientific statement for healthcare professionals from the American Heart Association/American Stroke Association
AU - Wechsler, Lawrence R.
AU - Demaerschalk, Bart M.
AU - Schwamm, Lee H.
AU - Adeoye, Opeolu M.
AU - Audebert, Heinrich J.
AU - Fanale, Christopher V.
AU - Hess, David C.
AU - Majersik, Jennifer J.
AU - Nystrom, Karin V.
AU - Reeves, Mathew J.
AU - Rosamond, Wayne D.
AU - Switzer, Jeffrey A.
N1 - Publisher Copyright:
© 2016 American Heart Association, Inc.
PY - 2017/1/1
Y1 - 2017/1/1
N2 - Purpose - Telestroke is one of the most frequently used and rapidly expanding applications of telemedicine, delivering much-needed stroke expertise to hospitals and patients. This document reviews the current status of telestroke and suggests measures for ongoing quality and outcome monitoring to improve performance and to enhance delivery of care. Methods - A literature search was undertaken to examine the current status of telestroke and relevant quality indicators. The members of the writing committee contributed to the review of specific quality and outcome measures with specific suggestions for metrics in telestroke networks. The drafts were circulated and revised by all committee members, and suggestions were discussed for consensus. Results - Models of telestroke and the role of telestroke in stroke systems of care are reviewed. A brief description of the science of quality monitoring and prior experience in quality measures for stroke is provided. Process measures, outcomes, tissue-type plasminogen activator use, patient and provider satisfaction, and telestroke technology are reviewed, and suggestions are provided for quality metrics. Additional topics include licensing, credentialing, training, and documentation.
AB - Purpose - Telestroke is one of the most frequently used and rapidly expanding applications of telemedicine, delivering much-needed stroke expertise to hospitals and patients. This document reviews the current status of telestroke and suggests measures for ongoing quality and outcome monitoring to improve performance and to enhance delivery of care. Methods - A literature search was undertaken to examine the current status of telestroke and relevant quality indicators. The members of the writing committee contributed to the review of specific quality and outcome measures with specific suggestions for metrics in telestroke networks. The drafts were circulated and revised by all committee members, and suggestions were discussed for consensus. Results - Models of telestroke and the role of telestroke in stroke systems of care are reviewed. A brief description of the science of quality monitoring and prior experience in quality measures for stroke is provided. Process measures, outcomes, tissue-type plasminogen activator use, patient and provider satisfaction, and telestroke technology are reviewed, and suggestions are provided for quality metrics. Additional topics include licensing, credentialing, training, and documentation.
KW - AHA Scientific Statements
KW - quality indicators, health care
KW - stroke
KW - telemedicine
KW - treatment outcome
UR - http://www.scopus.com/inward/record.url?scp=85007281336&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85007281336&partnerID=8YFLogxK
U2 - 10.1161/STR.0000000000000114
DO - 10.1161/STR.0000000000000114
M3 - Article
C2 - 27811332
AN - SCOPUS:85007281336
SN - 0039-2499
VL - 48
SP - e3-e25
JO - Stroke
JF - Stroke
IS - 1
ER -